-
intensive within-person trials in routine treatment to determine what works for whom and why. A key strength of this PhD project is its close integration with clinical practice. Methods are developed and
-
protective pathway. We hypothesize that boosting these intrinsic defenses offers a novel therapeutic approach. Intervening early in the disease progression may delay or even halt disease development. Would you
-
treatment for each patient, greatly improving treatment outcomes worldwide. Therefore, in this PhD project, you will fundamentally change how quantitative MRI is obtained and develop innovative AI approaches
-
underlying inherited forms of SCD, with the aim of developing new therapeutic strategies. In this context, the role of cell types other than cardiomyocytes is becoming increasingly relevant, opening up